All Resources A-Z |
Topic |
Available Resources |
Appropriate Prescribing for Obesity and Weight Loss
|
|
Appropriate Use of Stress Ulcer Prophylaxis (SUP)
|
|
Chronic Care Management
|
|
Chronic Kidney Disease
|
|
Clinical Insights & Education |
|
Clinical Services Frequently Asked Questions |
|
Clinical Support Programs |
|
CMDM Referrals Training |
|
Coding Education |
|
Deprescribing Clinical Pearl in Treatment of Type 2 Diabetes Mellitus |
|
Educational Reminder Cards for Members |
|
Emergency Department Utilization |
|
Geriatric Optimization - Antipsychotics |
|
Geriatric Optimization - Benzodiazepines |
|
Geriatric Deprescribing - Conversation Aid to Accompany Deprescribing |
|
Geriatric Optimization - Medications with Anticholinergic Properties |
|
Geriatric Optimization - Megestrol Acetate (Megace®) |
|
Geriatric Optimization - Muscle Relaxants |
|
Geriatric Optimization - Nonbenzodiazepine Benzodiazepine Receptor Agonist Hypnotics (i.e., Z drugs) |
|
Geriatric Optimization - Selective Alpha-1 Blockers |
|
Geriatric Optimization - Tricyclic Antidepressants (TCA) and Paroxetine (Paxil®) |
|
Major Joint Ortho Suite |
|
Medicare Advantage Quality Measures |
|
Medicare Advantage Stars |
|
Nutrition
|
|
Optimal Colorectal Cancer Screening
|
|
Palliative Care
|
|
Pharmacists Role in Transitions of Care
|
|
Pneumococcal Vaccine Recommendations
|
|
Preventing Gastrointestinal Bleeds While Taking Dual Antiplatelet Therapy (DAPT)
|
|
Proton Pump Inhibitor Deprescribing
|
|
Reference Guide of Highmark Member Programs
|
|
Social Determinants of Health
|
|
Specialty Management
|
|
Team-Based Care Model
|
- Introduction to Team-Based Care Model
|
Transitions of Care
|
|
Value-Based Care 101
|
|
Value Insight Center
|
|
Well360 Clarity
|
|